Cochlear sees no other suitors for Demant's implants business
20,000 patients currently using an Oticon Medical implant stand to lose if competition authorities continue to block Demant’s divestment of the surgical unit to Australia-based Cochlear.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app